SCM
BLUE

Suffolk Capital Management’s bluebird bio BLUE Stock Holding History

Suffolk Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-626
Closed -$1.37M – 143
2015
Q2 		$1.37M Sell
626
-595
-49% -$1.21M 0.16% 125
2015
Q1 		$1.91M Sell
1,221
-1,132
-48% -$1.49M 0.22% 125
2014
Q4 		$2.79M Buy
2,353
+1,110
+89% +$742K 0.34% 98
2014
Q3 		$578K Buy
+1,243
New +$574K 0.07% 131

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Suffolk Capital Management's BLUE Position: Q3 2015 in Review

Suffolk Capital Management sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 626 shares — an estimated $1.37M sold.

Suffolk Capital Management first reported a position in BLUE in Q3 2014 and held it in 4 quarters. The position peaked at $2.79M in Q4 2014. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

  • Suffolk Capital Management reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
  • Suffolk Capital Management sold 626 bluebird bio shares in Q3 2015, an estimated $1.37M.
  • Suffolk Capital Management first reported a position in bluebird bio in Q3 2014 and held it in 4 quarters.
  • Suffolk Capital Management's bluebird bio position peaked at $2.79M in Q4 2014.
  • 192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on Suffolk Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.